School personnel information

写真b

Niki Kazuyuki


Keyword

Clinical Pharmacy, Palliative Care

Mail Address

Mail Address

URL

https://phs-osaka-u-ryouyaku.jimdo.com/

Organization 【 display / non-display

  • 2013.04.16 - 2013.07.15, Center for Advanced Eduction and Research in Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Assistant Professor

  • 2013.07.16 - , Center for Advanced Eduction and Research in Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Assistant Professor

  • 2019.12.01 - , Graduate School of Medicine

Education 【 display / non-display

Osaka University Faculty of Pharmaceutical Science  Graduated 2013.03
Osaka University Faculty of Pharmaceutical Science  2019.03

Research topics 【 display / non-display

  • Palliative care
    Clinical pharmacy-related

 

Academic Papers 【 display / non-display

  • The adequateness of methadone for Japanese terminal cancer patients can be determined earlier than 7 days: a preliminary retrospective study., Takemura M, Niki K*, Okamoto Y, Matsuda Y, Ueda M, Uejima E., JMA Journal,3(3) 258-264, 2020.07, Papers

  • Response to Wang et al. (doi: 10.1089/jpm.2020.0212): Virtual Reality as a Bridge in Palliative Care during COVID-19, Niki K*, Okamoto Y, Ueda M, Journal of Palliative Medicine,23(7) 892-894, 2020.07, Papers

  • Persistence, effects, and adverse events associated with real-world daily teriparatide use in Japanese patients with osteoporosis., Matsumoto T, Niki K, Hatabu A, Oshima T, Sato K, Ueda M, Sato T, Uejima E, BPB Reports,3(1) 39-44, 2020.02, Papers

  • Responses to Kako et al. (DOI:10.1089/jpm.2019.0072) and Niki et al. (DOI: 10.1089/jpm.2018.0233): A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study., Niki K*, Okamoto Y, Maeda I, Ueda M, Journal of Palliative Medicine,22(12), 1490, 2019.12, Papers

  • 11β-hydroxysteroid dehydrogenase type 1 is associated with antiretroviral therapy-induced increase in low-density lipoprotein cholesterol., Niki K, Harada K, Hikasa S, Tsugane M, Ueda M, Higasa S, Kimura T, Takagi T, Uejima E, International Journal of Clinical Pharmacology and Therapeutics,57(6), 298-305, 2019.06, Papers

display all >>